Bailard’s Pediatrix Medical MD Stock Holding History

Bailard’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$755K	Buy	35,300 +2,800	+9%	+$58.3K	0.02%	395
2025 Q4	$695K	Sell	32,500 -9,700	-23%	-$199K	0.02%	406
2025 Q3	$707K	Buy	+42,200	New	+$632K	0.02%	414
2025 Q2	–	Sell	-43,300	Closed	-$627K	–	808
2025 Q1	$627K	Buy	43,300 +31,000	+252%	+$440K	0.02%	412
2024 Q4	$161K	Buy	+12,300	New	+$170K	﹤0.01%	702
2020 Q4	–	Sell	-19,900	Closed	-$324K	–	658
2020 Q3	$324K	Buy	+19,900	New	+$370K	0.02%	373
2020 Q1	–	Sell	-15,550	Closed	-$432K	–	529
2019 Q4	$432K	Sell	15,550 -1,500	-9%	-$37.6K	0.02%	323
2019 Q3	$386K	Buy	17,050 +1,400	+9%	+$31.9K	0.02%	338
2019 Q2	$395K	Buy	+15,650	New	+$420K	0.02%	347
2019 Q1	–	Sell	-9,762	Closed	-$322K	–	571
2018 Q4	$322K	Buy	+9,762	New	+$392K	0.02%	406

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bailard's MD Position: Q1 2026 in Review

Bailard increased its Pediatrix Medical (MD) stake by 8.6% in Q1 2026, buying an estimated $58.3K and bringing the position to 35,300 shares worth $755K. The position accounts for 0.02% of the portfolio, ranked #395.

Bailard first reported a position in MD in Q4 2018 and has held it in 10 quarters since. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Bailard held 35,300 shares of Pediatrix Medical worth $755K as of Q1 2026.
Bailard bought 2,800 Pediatrix Medical shares in Q1 2026, an estimated $58.3K.
Pediatrix Medical made up 0.02% of Bailard's portfolio in Q1 2026, its #395 holding.
Bailard first reported a position in Pediatrix Medical in Q4 2018 and has held it in 10 quarters since.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.